Volastra Therapeutics
New York
About Volastra Therapeutics
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $149.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: volastratx.com
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/volastra-therapeutics-60770 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.